Contineum Therapeutics, Inc. (CTNM) Net income 2023–2025
Contineum Therapeutics, Inc. (CTNM) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$60.0MFY2025 · since FY2023: $22.7M → -$60.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$60.0M | -41.9% |
| FY2024 | -$42.3M | -286.0% |
| FY2023 | $22.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice